Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
146.2 USD | -0.40% | -1.54% | -6.33% |
Apr. 29 | J&J, Bristol Myers lose challenges to US drug price negotiation program | RE |
Apr. 29 | J&J: positive CHMP opinion for lung cancer | CF |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-6.33% | 354B | |
+26.47% | 664B | |
+27.57% | 567B | |
+19.35% | 330B | |
+4.23% | 286B | |
+13.45% | 234B | |
+4.76% | 199B | |
-10.18% | 196B | |
-4.04% | 148B | |
-10.94% | 145B |
- Stock Market
- Equities
- JNJ Stock
- News Johnson & Johnson
- Raymond James Adjusts Johnson & Johnson's Price Target to $170 From $175, Maintains Outperform Rating